구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-5 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein (Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein) Mayo Clinic·Anatomic Stage IV Breast Cancer AJ… 1 trials |
|---|---|
Overview Program | Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein |
Overview Company | Mayo Clinic |
Overview Modality | CGT |
Overview Target | Anatomic Stage IV Breast Cancer AJCC v8 |
Overview Indication | Anatomic Stage IV Breast Cancer AJCC v8; Invasive Breast Carcinoma |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.. Helicobacter pylori neutrophil-activating protein (NAP) is a major virulence factor and powerful inducer of inflammatory reaction and Th1-polarized immune response. Here, we evaluated the therapeutic efficacy of measles virus (MV) strains engineered to ex… |
Clinical Safety signal | Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.. Helicobacter pylori neutrophil-activating protein (NAP) is a major virulence factor and powerful inducer of inflammatory reaction and Th1-polarized immune response. Here, we evaluated the therapeutic efficacy of measles virus (MV) strains engineered to ex… |
Clinical Program phase | PHASE_1 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-5 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein (Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein) Mayo Clinic·Anatomic Stage IV Breast Cancer AJ… 1 trials |
|---|---|
Overview Program | Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein |
Overview Company | Mayo Clinic |
Overview Modality | CGT |
Overview Target | Anatomic Stage IV Breast Cancer AJCC v8 |
Overview Indication | Anatomic Stage IV Breast Cancer AJCC v8; Invasive Breast Carcinoma |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.. Helicobacter pylori neutrophil-activating protein (NAP) is a major virulence factor and powerful inducer of inflammatory reaction and Th1-polarized immune response. Here, we evaluated the therapeutic efficacy of measles virus (MV) strains engineered to ex… |
Clinical Safety signal | Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.. Helicobacter pylori neutrophil-activating protein (NAP) is a major virulence factor and powerful inducer of inflammatory reaction and Th1-polarized immune response. Here, we evaluated the therapeutic efficacy of measles virus (MV) strains engineered to ex… |
Clinical Program phase | PHASE_1 |
추천 비교
추천 비교